SCOPUS 정보 검색 플랫폼

Volumn , Issue , 2006, Pages 346-359

Controversies in the early reporting of a clinical trial in early breast cancer

Author keywords

[No Author keywords available]

Indexed keywords

EID: 63749118783 PISSN: None EISSN: None Source Type: Book
DOI: 10.1007/0-387-30107-0_34 Document Type: Chapter

Times cited : (1)

References (9)

1
- 0038383613
- The role of taxanes in the adjuvant treatment of early stage breast cancer
- Piccart M. 2003. The role of taxanes in the adjuvant treatment of early stage breast cancer. Breast Cancer Research and Treatment 79:S25-S34.
- (2003) Breast Cancer Research and Treatment , vol.79
- Piccart, M.¹

2
- 0041921059
- Landmark adjuvant randomized clinical trials of systemic therapy in early breast cancer
- Cardoso F, Lohrisch C, Piccart MJ. 2003. Landmark adjuvant randomized clinical trials of systemic therapy in early breast cancer. Drugs of Today 39:399-414.
- (2003) Drugs of Today , vol.39 , pp. 399-414
- Cardoso, F.¹ Lohrisch, C.² Piccart, M.J.³

3
- 0037445132
- Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer
- Henderson IC, Berry DA, Demetri GD, Cirrincione CT, Goldstein LJ, Martino S, et al. 2003. Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer. J Clin Oncol 21:976-983.
- (2003) J Clin Oncol , vol.21 , pp. 976-983
- Henderson, I.C.¹ Berry, D.A.² Demetri, G.D.³ Cirrincione, C.T.⁴ Goldstein, L.J.⁵ Martino, S.⁶

4
- 0018687930
- A multiple testing procedure for clinical trials
- O'Brien PC, Fleming TR. 1979. A multiple testing procedure for clinical trials. Biometrics 35:549-556.
- (1979) Biometrics , vol.35 , pp. 549-556
- O'Brien, P.C.¹ Fleming, T.R.²

5
- 4444378775
- Strength of accumulating evidence and data monitoring committee decision making
- George SL, Freidlin B, Korn EL. 2004. Strength of accumulating evidence and data monitoring committee decision making. Stat Med 23:2659-2672.
- (2004) Stat Med , vol.23 , pp. 2659-2672
- George, S.L.¹ Freidlin, B.² Korn, E.L.³

6
- 0001261990
- Improved disease-free (DFS) and overall survival (OS) from the addition of sequential paclitaxel (T) but not from the escalation of doxorubicin (A) dose level in the adjuvant chemotherapy of patients with node-positive primary breast cancer
- Henderson IC, Berry DA, Demetri GD, Cirrincione CT, Goldstein LJ, Martino S, Ingle JN, et al. 1998. Improved disease-free (DFS) and overall survival (OS) from the addition of sequential paclitaxel (T) but not from the escalation of doxorubicin (A) dose level in the adjuvant chemotherapy of patients with node-positive primary breast cancer. Proc ASCO 17:390a.
- (1998) Proc ASCO , vol.17
- Henderson, I.C.¹ Berry, D.A.² Demetri, G.D.³ Cirrincione, C.T.⁴ Goldstein, L.J.⁵ Martino, S.⁶ Ingle, J.N.⁷

8
- 0035756540
- Taxanes in the adjuvant treatment of breast cancer: Why not yet?
- Piccart MJ, Lohrisch C, Duchateau L, Buyse M. 2001. Taxanes in the adjuvant treatment of breast cancer: Why not yet? J Natl Cancer Inst Monogr 30:88-95.
- (2001) J Natl Cancer Inst Monogr , vol.30 , pp. 88-95
- Piccart, M.J.¹ Lohrisch, C.² Duchateau, L.³ Buyse, M.⁴

9
- 0032863539
- Data monitoring committees and interim monitoring guidelines
- Freidlin B, Korn EL, George SL. 1999. Data monitoring committees and interim monitoring guidelines. Control Clin Trials 20:395-407.
- (1999) Control Clin Trials , vol.20 , pp. 395-407
- Freidlin, B.¹ Korn, E.L.² George, S.L.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.